12/09/2024 | Press release | Distributed by Public on 12/09/2024 15:11
Fourth Quarter Fiscal 2025
|
Full Year Fiscal 2025 | |
Revenue | $515.0 million to $519.0 million | $1.973 billion to $1.977 billion |
Non-GAAP Income from Operations | $55.0 million to $58.0 million | $241.8 million to $244.8 million |
Non-GAAP Net Income per Share | $0.62 to $0.65 | $3.01 to $3.03 |
October 31, 2024 | January 31, 2024 | |||
Assets
|
||||
Current assets: | ||||
Cash and cash equivalents
|
$ | 673,054 | $ | 802,959 |
Short-term investments | 1,629,038 | 1,212,448 | ||
Accounts receivable, net of allowance for doubtful accounts of $8,212 and $8,054 as of October 31, 2024 and January 31, 2024, respectively | 334,629 | 325,610 | ||
Deferred commissions
|
103,715 | 92,512 | ||
Prepaid expenses and other current assets
|
53,827 | 50,107 | ||
Total current assets
|
2,794,263 | 2,483,636 | ||
Property and equipment, net | 47,345 | 53,042 | ||
Operating lease right-of-use assets | 35,859 | 37,365 | ||
Goodwill | 69,679 | 69,679 | ||
Acquired intangible assets, net | 963 | 3,957 | ||
Deferred tax assets | 5,575 | 4,116 | ||
Other assets
|
271,101 | 217,847 | ||
Total assets
|
$ | 3,224,785 | $ | 2,869,642 |
Liabilities and Stockholders' Equity | ||||
Current liabilities: | ||||
Accounts payable
|
$ | 11,444 | $ | 9,905 |
Accrued compensation and benefits
|
120,598 | 112,579 | ||
Operating lease liabilities
|
10,787 | 9,797 | ||
Other accrued liabilities
|
86,795 | 74,831 | ||
Deferred revenue
|
286,431 | 357,108 | ||
Convertible senior notes, net
|
1,124,720 | - | ||
Total current liabilities
|
1,640,775 | 564,220 | ||
Deferred tax liability | 1,030 | 285 | ||
Operating lease liabilities
|
27,639 | 30,918 | ||
Deferred revenue
|
18,481 | 20,296 | ||
Convertible senior notes, net
|
- | 1,143,273 | ||
Other liabilities
|
34,884 | 41,661 | ||
Total liabilities
|
1,722,809 | 1,800,653 | ||
Stockholders' equity: | ||||
Common stock, par value of $0.001 per share; 1,000,000,000 shares authorized as of October 31, 2024 and January 31, 2024; 74,493,146 shares issued and 74,393,775 shares outstanding as of October 31, 2024; 72,840,692 shares issued and 72,741,321 shares outstanding as of January 31, 2024
|
73 | 73 | ||
Additional paid-in capital | 3,357,146 | 2,777,322 | ||
Treasury stock, 99,371 shares (repurchased at an average of $13.27 per share) as of October 31, 2024 and January 31, 2024
|
(1,319) | (1,319) | ||
Accumulated other comprehensive income | 2,606 | 4,545 | ||
Accumulated deficit
|
(1,856,530) | (1,711,632) | ||
Total stockholders' equity | 1,501,976 | 1,068,989 | ||
Total liabilities and stockholders' equity | $ | 3,224,785 | $ | 2,869,642 |
Three Months Ended October 31, | Nine Months Ended October 31, | |||||||
2024 | 2023 | 2024 | 2023 | |||||
Revenue:
|
||||||||
Subscription
|
$ | 512,205 | $ | 418,339 | $ | 1,412,906 | $ | 1,182,387 |
Services
|
17,170 | 14,599 | 45,139 | 42,622 | ||||
Total revenue
|
529,375 | 432,938 | 1,458,045 | 1,225,009 | ||||
Cost of revenue: | ||||||||
Subscription(1)
|
111,150 | 87,954 | 318,728 | 250,949 | ||||
Services(1)
|
24,181 | 19,104 | 67,553 | 58,895 | ||||
Total cost of revenue
|
135,331 | 107,058 | 386,281 | 309,844 | ||||
Gross profit | 394,044 | 325,880 | 1,071,764 | 915,165 | ||||
Operating expenses:
|
||||||||
Sales and marketing(1)
|
217,954 | 192,977 | 658,937 | 571,644 | ||||
Research and development(1)
|
151,410 | 128,150 | 446,437 | 370,387 | ||||
General and administrative(1)
|
52,556 | 49,969 | 163,892 | 135,900 | ||||
Total operating expenses
|
421,920 | 371,096 | 1,269,266 | 1,077,931 | ||||
Loss from operations
|
(27,876) | (45,216) | (197,502) | (162,766) | ||||
Other income, net | 20,767 | 19,554 | 61,749 | 51,336 | ||||
Loss before provision for income taxes | (7,109) | (25,662) | (135,753) | (111,430) | ||||
Provision for income taxes | 2,667 | 3,635 | 9,145 | 9,710 | ||||
Net loss
|
$ | (9,776) | $ | (29,297) | $ | (144,898) | $ | (121,140) |
Net loss per share, basic and diluted
|
$ | (0.13) | $ | (0.41) | $ | (1.97) | $ | (1.71) |
Weighted-average shares used to compute net loss per share, basic and diluted
|
74,020,593 | 71,560,023 | 73,472,900 | 70,878,162 |
Three Months Ended October 31, | Nine Months Ended October 31, | |||||||
2024 | 2023 | 2024 | 2023 | |||||
Cost of revenue-subscription
|
$ | 7,884 | $ | 6,018 | $ | 21,566 | $ | 17,607 |
Cost of revenue-services
|
3,495 | 3,200 | 10,151 | 9,490 | ||||
Sales and marketing
|
40,540 | 40,585 | 121,193 | 118,567 | ||||
Research and development
|
57,850 | 50,759 | 168,211 | 143,238 | ||||
General and administrative
|
15,943 | 15,267 | 47,777 | 44,194 | ||||
Total stock-based compensation expense
|
$ | 125,712 | $ | 115,829 | $ | 368,898 | $ | 333,096 |
Three Months Ended October 31, | Nine Months Ended October 31, | |||||||
2024 | 2023 | 2024 | 2023 | |||||
Cash flows from operating activities | ||||||||
Net loss | $ | (9,776) | $ | (29,297) | $ | (144,898) | $ | (121,140) |
Adjustments to reconcile net loss to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 2,405 | 4,711 | 9,580 | 13,257 | ||||
Stock-based compensation | 125,712 | 115,829 | 368,898 | 333,096 | ||||
Amortization of debt discount and issuance costs | 715 | 849 | 2,419 | 2,543 | ||||
Amortization of finance right-of-use assets | 994 | 994 | 2,981 | 2,981 | ||||
Amortization of operating right-of-use assets | 3,229 | 2,302 | 8,300 | 6,781 | ||||
Deferred income taxes | (825) | (195) | (799) | (572) | ||||
Amortization of premium and accretion of discount on short-term investments, net | (5,656) | (10,896) | (19,117) | (36,405) | ||||
Realized and unrealized gain on financial instruments, net | (338) | - | (1,190) | (1,294) | ||||
Unrealized foreign exchange loss (gain) | 788 | (1,621) | 1,992 | (322) | ||||
Change in operating assets and liabilities: | ||||||||
Accounts receivable, net | (24,557) | (397) | (11,258) | 11,761 | ||||
Prepaid expenses and other current assets | (1,964) | 3,485 | (582) | 700 | ||||
Deferred commissions | (18,821) | (12,720) | (38,794) | (17,160) | ||||
Other long-term assets | (8,395) | (77) | (17,704) | (215) | ||||
Accounts payable | 1,370 | 1,434 | 1,569 | 1,078 | ||||
Accrued liabilities | (6,719) | 16,855 | 22,494 | 20,314 | ||||
Operating lease liabilities | (3,777) | (2,333) | (9,145) | (6,989) | ||||
Deferred revenue
|
(17,039) | (47,374) | (71,352) | (138,724) | ||||
Other liabilities, non-current
|
92 | (3,127) | (3,741) | (2,840) | ||||
Net cash provided by operating activities | 37,438 | 38,422 | 99,653 | 66,850 | ||||
Cash flows from investing activities | ||||||||
Purchases of property and equipment | (1,981) | (2,078) | (3,571) | (3,336) | ||||
Investments in non-marketable securities | (250) | - | (5,750) | (2,056) | ||||
Business combinations, net of cash acquired | - | (15,000) | - | (15,000) | ||||
Proceeds from maturities of marketable securities | 135,000 | 435,000 | 570,000 | 1,190,000 | ||||
Purchases of marketable securities
|
(786,170) | (583,252) | (971,803) | (1,233,851) | ||||
Net cash used in investing activities | (653,401) | (165,330) | (411,124) | (64,243) | ||||
Cash flows from financing activities | ||||||||
Proceeds from settlement of capped calls | - | - | 170,589 | - | ||||
Proceeds from the issuance of common stock under the Employee Stock Purchase Plan | - | - | 18,640 | 19,781 | ||||
Proceeds from exercise of stock options | 315 | 1,303 | 1,621 | 4,812 | ||||
Principal payments of finance leases
|
(895) | (1,380) | (4,534) | (4,083) | ||||
Net cash (used in) provided by financing activities | (580) | (77) | 186,316 | 20,510 | ||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
(274) | (2,513) | (2,825) | (1,098) | ||||
Net (decrease) increase in cash, cash equivalents and restricted cash | (616,817) | (129,498) | (127,980) | 22,019 | ||||
Cash, cash equivalents and restricted cash, beginning of period
|
1,292,480 | 607,856 | 803,643 | 456,339 | ||||
Cash, cash equivalents and restricted cash, end of period
|
$ | 675,663 | $ | 478,358 | $ | 675,663 | $ | 478,358 |
Three Months Ended October 31, | Nine Months Ended October 31, | |||||||
2024 | 2023 | 2024 | 2023 | |||||
Reconciliation of GAAP gross profit to non-GAAP gross profit: | ||||||||
Gross profit on a GAAP basis | $ | 394,044 | $ | 325,880 | $ | 1,071,764 | $ | 915,165 |
Gross margin (Gross profit/Total revenue) on a GAAP basis | 74 | % | 75 | % | 74 | % | 75 | % |
Add back: | ||||||||
Expenses associated with stock-based compensation: Cost of Revenue-Subscription | 7,999 | 6,201 | 22,145 | 18,252 | ||||
Expenses associated with stock-based compensation: Cost of Revenue-Services | 3,639 | 3,194 | 10,393 | 10,734 | ||||
Non-GAAP gross profit | $ | 405,682 | $ | 335,275 | $ | 1,104,302 | $ | 944,151 |
Non-GAAP gross margin (Non-GAAP gross profit/Total revenue) | 77 | % | 77 | % | 76 | % | 77 | % |
Reconciliation of GAAP operating expenses to non-GAAP operating expenses: | ||||||||
Sales and marketing operating expense on a GAAP basis | $ | 217,954 | $ | 192,977 | $ | 658,937 | $ | 571,644 |
Less: | ||||||||
Expenses associated with stock-based compensation | 42,155 | 42,349 | 125,129 | 130,638 | ||||
Amortization of intangible assets | - | 760 | 85 | 2,280 | ||||
Non-GAAP sales and marketing operating expense | $ | 175,799 | $ | 149,868 | $ | 533,723 | $ | 438,726 |
Research and development operating expense on a GAAP basis | $ | 151,410 | $ | 128,150 | $ | 446,437 | $ | 370,387 |
Less: | ||||||||
Expenses associated with stock-based compensation | 59,017 | 52,133 | 173,166 | 148,679 | ||||
Amortization of intangible assets | 170 | 2,052 | 2,908 | 5,122 | ||||
Non-GAAP research and development operating expense | $ | 92,223 | $ | 73,965 | $ | 270,363 | $ | 216,586 |
General and administrative operating expense on a GAAP basis | $ | 52,556 | $ | 49,969 | $ | 163,892 | $ | 135,900 |
Less: | ||||||||
Expenses associated with stock-based compensation | 16,377 | 17,024 | 50,469 | 48,329 | ||||
Non-GAAP general and administrative operating expense | $ | 36,179 | $ | 32,945 | $ | 113,423 | $ | 87,571 |
Reconciliation of GAAP loss from operations to non-GAAP income from operations: | ||||||||
Loss from operations on a GAAP basis | $ | (27,876) | $ | (45,216) | $ | (197,502) | $ | (162,766) |
GAAP operating margin (Loss from operations/Total revenue) | (5) | % | (10) | % | (14) | % | (13) | % |
Add back: | ||||||||
Expenses associated with stock-based compensation | 129,186 | 120,901 | 381,303 | 356,632 | ||||
Amortization of intangible assets | 170 | 2,812 | 2,993 | 7,402 | ||||
Non-GAAP income from operations | $ | 101,480 | $ | 78,497 | $ | 186,794 | $ | 201,268 |
Non-GAAP operating margin (Non-GAAP Income from operations/Total revenue) | 19 | % | 18 | % | 13 | % | 16 | % |
Three Months Ended October 31, | Nine Months Ended October 31, | |||||||
2024 | 2023 | 2024 | 2023 | |||||
Reconciliation of GAAP net loss to non-GAAP net income: | ||||||||
Net loss on a GAAP basis | $ | (9,776) | $ | (29,297) | $ | (144,898) | $ | (121,140) |
Add back: | ||||||||
Expenses associated with stock-based compensation | 129,186 | 120,901 | 381,303 | 356,632 | ||||
Amortization of intangible assets | 170 | 2,812 | 2,993 | 7,402 | ||||
Amortization of debt issuance costs related to convertible senior notes | 716 | 849 | 2,419 | 2,543 | ||||
Less: | ||||||||
Gains on financial instruments, net | 338 | - | 1,190 | 1,294 | ||||
Income tax effects and adjustments *
|
21,858 | 16,145 | 40,809 | 41,061 | ||||
Non-GAAP net income | $ | 98,100 | $ | 79,120 | $ | 199,818 | $ | 203,082 |
Reconciliation of GAAP net loss per share, basic and diluted, to non-GAAP net income per share, basic and diluted: | ||||||||
Net loss per share, basic and diluted, on a GAAP basis | $ | (0.13) | $ | (0.41) | $ | (1.97) | $ | (1.71) |
Add back: | ||||||||
Expenses associated with stock-based compensation | 1.75 | 1.69 | 5.19 | 5.03 | ||||
Amortization of intangible assets | - | 0.04 | 0.04 | 0.10 | ||||
Amortization of debt issuance costs related to convertible senior notes | 0.01 | 0.01 | 0.03 | 0.04 | ||||
Less: | ||||||||
Gains on financial instruments, net | - | - | 0.02 | 0.02 | ||||
Income tax effects and adjustments * | 0.30 | 0.23 | 0.56 | 0.58 | ||||
Non-GAAP net income per share, basic | $ | 1.33 | $ | 1.10 | $ | 2.71 | $ | 2.86 |
Adjustment for fully diluted earnings per share | (0.17) | (0.14) | (0.32) | (0.39) | ||||
Non-GAAP net income per share, diluted ** | $ | 1.16 | $ | 0.96 | $ | 2.39 | $ | 2.47 |
Three Months Ended October 31, | Nine Months Ended October 31, | |||||||
2024 | 2023 | 2024 | 2023 | |||||
Net cash provided by operating activities | $ | 37,438 | $ | 38,422 | $ | 99,653 | $ | 66,850 |
Capital expenditures | (1,981) | (2,078) | (3,571) | (3,336) | ||||
Principal repayments of finance leases | (895) | (1,380) | (4,534) | (4,083) | ||||
Capitalized software | - | - | - | - | ||||
Free cash flow
|
$ | 34,562 | $ | 34,964 | $ | 91,548 | $ | 59,431 |
10/31/2022 | 1/31/2023 | 4/30/2023 | 7/31/2023 | 10/31/2023 | 1/31/2024 | 4/30/2024 | 7/31/2024 | 10/31/2024 | |
Total Customers (a)
|
39,100+ | 40,800+ | 43,100+ | 45,000+ | 46,400+ | 47,800+ | 49,200+ | 50,700+ | 52,600+ |
Direct Sales Customers(b)
|
5,900+ | 6,400+ | 6,700+ | 6,800+ | 6,900+ | 7,000+ | 7,100+ | 7,300+ | 7,400+ |
MongoDB Atlas Customers
|
37,600+ | 39,300+ | 41,600+ | 43,500+ | 44,900+ | 46,300+ | 47,700+ | 49,200+ | 51,100+ |
Customers over $100K(c)
|
1,545 | 1,651 | 1,761 | 1,855 | 1,972 | 2,052 | 2,137 | 2,189 | 2,314 |
10/31/2022 |
1/31/2023
|
4/30/2023
|
7/31/2023
|
10/31/2023
|
1/31/2024 |
4/30/2024
|
7/31/2024
|
10/31/2024
|
||||||||||
MongoDB Enterprise Advanced: % of Subscription Revenue
|
29 | % | 28 | % | 28 | % | 26 | % | 27 | % | 26 | % | 25 | % | 24 | % | 25 | % |
Direct Sales Customers(a)
Revenue: % of Subscription Revenue
|
87 | % | 88 | % | 88 | % | 88 | % | 88 | % | 88 | % | 87 | % | 87 | % | 88 | % |